ReviewFrontiers in immunology2026
Biomaterial physicochemical properties govern immune activation and bone regeneration: a titanium-focused design-oriented osteoimmunological framework.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Therapeutic Dilemma to Precision Modulation: Harnessing Biomaterials to Target the Dual Face of TGF-β in Osteoarthritis.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The host immune response is increasingly recognized as a critical determinant of implant performance and bone regeneration in craniofacial applications. In osteoimmunology, macrophages act as central regulators of the foreign body response by integrating material-derived cues with intracellular signaling pathways that control inflammation and tissue repair. In this context, biomaterials actively regulate the immune microenvironment. However, the integration of biomaterial physicochemical properties with immune signaling and regenerative outcomes remains incomplete. Here, a mechanistic and design-oriented perspective on osteoimmunological processes governing biomaterial-tissue interactions is provided, with a particular focus on macrophage polarization, cytokine signaling networks, and apoptosis pathways involved in bone remodeling. Special attention is given to titanium wear particles as key immunological stimuli that activate macrophages through NF-κB, MAPK, and STAT signaling pathways, as well as emerging mechanisms including inflammasome activation and immunometabolic reprogramming. A unified osteoimmunological framework is introduced that integrates biomaterial physicochemical properties with immune signaling pathways and regenerative outcomes. Within this framework, material-induced modulation of macrophage phenotypes and cytokine profiles is identified as a central design axis controlling the balance between inflammation and regeneration. Emerging immunomodulatory strategies are discussed, including surface nanoengineering, ion-releasing systems, bioactive coatings, and stimuli-responsive biomaterials enabling spatiotemporal control of immune responses. Key limitations, including the oversimplified classification of macrophage phenotypes and the limited translational relevance of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.